Literature DB >> 21726050

Proteomic signatures in antibiotic research.

Michaela Wenzel1, Julia E Bandow.   

Abstract

Antibiotics disturb the physiological homeostasis of bacterial cells by interfering with essential cellular functions or structures. The bacterial proteome adjusts quickly in response to antibiotic challenge. This physiological response is specifically tailored to overcome the inflicted damage and, thus, closely linked to the antibiotic target and mechanism of action. In a way, the proteome mirrors the antibiotic insult. This connection can be exploited to guide the development of novel antibiotics. By using structurally different antibiotics, which cause the same physiological disturbance, proteomic signatures diagnostic of the mechanism of action can be defined. These proteomic signatures inform about mechanism-related differential protein expression as well as about protein modifications. This review recapitulates how antibiotic proteomic signatures are established and highlights areas of antibiotic research benefiting most from proteomic signatures. Antibacterial research programs designed to structurally advance existing antibiotic classes profit from rapid in vivo mechanism of action confirmation. What is more, a comprehensive reference compendium of antibiotic proteomic signatures allows rapid mechanism of action identification of those structurally novel compounds that inhibit known targets. Finally, novel proteomic response profiles indicate unprecedented mechanisms. Here, the proteome profile provides evidence on the nature of the antibiotic-caused physiological disturbance leading to testable hypotheses on the mechanism of action.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Mesh:

Substances:

Year:  2011        PMID: 21726050     DOI: 10.1002/pmic.201100046

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  19 in total

1.  Proteomics technology - a powerful tool for the biomedical scientists.

Authors:  Rahmah Noordin; Nurulhasanah Othman
Journal:  Malays J Med Sci       Date:  2013-03

2.  Natural low-molecular mass organic compounds with oxidase activity as organocatalysts.

Authors:  Tatsuya Nishiyama; Yoshiteru Hashimoto; Hitoshi Kusakabe; Takuto Kumano; Michihiko Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-19       Impact factor: 11.205

3.  Resistance phenotypes mediated by aminoacyl-phosphatidylglycerol synthases.

Authors:  Wiebke Arendt; Stefanie Hebecker; Sonja Jäger; Manfred Nimtz; Jürgen Moser
Journal:  J Bacteriol       Date:  2012-01-20       Impact factor: 3.490

4.  Further insights into the mode of action of the lipoglycopeptide telavancin through global gene expression studies.

Authors:  Yang Song; Christopher S Lunde; Bret M Benton; Brian J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2012-03-12       Impact factor: 5.191

5.  Adaptive Responses of Pseudomonas aeruginosa to Treatment with Antibiotics.

Authors:  Dominik Wüllner; Maren Gesper; Annika Haupt; Xiaofei Liang; Pei Zhou; Pascal Dietze; Franz Narberhaus; Julia E Bandow
Journal:  Antimicrob Agents Chemother       Date:  2021-11-08       Impact factor: 5.938

6.  Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.

Authors:  Michaela Wenzel; Bastian Kohl; Daniela Münch; Nadja Raatschen; H Bauke Albada; Leendert Hamoen; Nils Metzler-Nolte; Hans-Georg Sahl; Julia E Bandow
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

7.  The lantibiotic NAI-107 binds to bactoprenol-bound cell wall precursors and impairs membrane functions.

Authors:  Daniela Münch; Anna Müller; Tanja Schneider; Bastian Kohl; Michaela Wenzel; Julia Elisabeth Bandow; Sonia Maffioli; Margherita Sosio; Stefano Donadio; Reinhard Wimmer; Hans-Georg Sahl
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

8.  The anti-MRSA compound 3-O-alpha-L-(2″,3″-di-p-coumaroyl)rhamnoside (KCR) inhibits protein synthesis in Staphylococcus aureus.

Authors:  Nicholas J Carruthers; Paul M Stemmer; Joe Media; Ken Swartz; Xiaojuan Wang; Nicholas Aube; Mark T Hamann; Frederick Valeriote; Jiajiu Shaw
Journal:  J Proteomics       Date:  2019-10-17       Impact factor: 4.044

9.  CO-Releasing Molecules Have Nonheme Targets in Bacteria: Transcriptomic, Mathematical Modeling and Biochemical Analyses of CORM-3 [Ru(CO)3Cl(glycinate)] Actions on a Heme-Deficient Mutant of Escherichia coli.

Authors:  Jayne Louise Wilson; Lauren K Wareham; Samantha McLean; Ronald Begg; Sarah Greaves; Brian E Mann; Guido Sanguinetti; Robert K Poole
Journal:  Antioxid Redox Signal       Date:  2015-04-28       Impact factor: 8.401

10.  Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups.

Authors:  H Bauke Albada; Alina-Iulia Chiriac; Michaela Wenzel; Maya Penkova; Julia E Bandow; Hans-Georg Sahl; Nils Metzler-Nolte
Journal:  Beilstein J Org Chem       Date:  2012-10-15       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.